+0.14%
Today
Loading 1D prices…
Company profile
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Jerusalem, Israel, United States
Employees
129
CIK
1505065
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| DCTHDelcath Systems Inc. Common Stock | $552.1M | $85.2M | +3.17% | $0.07 | +0.66% | Buy |
| KIDSOrthoPediatrics Corp. Common Stock | $576M | $236.3M | -16.78% | -$1.69 | +2.32% | Buy |
| TCMDTactile Systems Technology Inc. Common Stock | $507.4M | $329.5M | +5.79% | $0.82 | +0.31% | Buy |
| CERSCerus Corporation Common Stock | $501.8M | $233.8M | -6.68% | -$0.08 | +0.81% | Buy |
| ANGOAngioDynamics Inc. Common Stock | $631.1M | $320.2M | -11.48% | -$0.88 | +0.20% | Buy |